Global Electroactive Polymers Market Trends, Applications and Forecasts (2012 - 2017)

Global Electroactive Polymers Market Trends, Applications and Forecasts (2012 - 2017)

For more details on the content of report and ordering information please visit:

http://www.aarkstore.com/reports/reportid-92988.html

Technological developments in the electronics and semiconductor industries have led to the creation of polymers that change shape on the application of voltage. The biggest application for electro-active polymers (EAPs) lays in their use in antistatic and electronic applications which is expected to drive its market growth. Among all EAP applications market, the actuator segment is witnessing high R&D activity and medical devices and robotics will be the largest applications of EAP actuators. Actuators and sensors open up a huge spectrum of applications in the fields of electronics, healthcare, sensing, and solar energy generation. With the growing market for each of these applications, EAP is set to become a mainstream market in the next five years. However, the technical specifications for each application differ widely, and extensive research and investments are still needed for developing application-specific EAPs.

The global electro-active polymers product market is expected to be worth $3.4 billion by 2017 and is forecasted to grow by a CAGR of 7.7% from 2012–2017. The conductive plastics segment contributed approximately 84% to the overall electro-active polymer market in 2011, mainly due to its extensive application in electrostatic discharge and electromagnetic interference. As the EAP market is still in the early phase of its growth, it presents many advantages for the early movers. As there are not many players in the market, detailed knowledge of the competitors will be crucial for the success of each company.

The report covers major electro-active polymers which include primarily conductive plastics, inherently conductive polymers (ICPs), and inherently dissipative polymers (IDPs) segments. It also studies other electro-active polymers such as dielectric elastomers and ferroelectrets. The report analyses the market for electro-active polymers with respect to market drivers, opportunities, and winning imperatives related to the industry.

The qualitative analysis of electro-active polymers with respect to its characteristics, parental structure, and business processes which are use by different companies is done in an elaborative manner. Based on the applications, the global electro-active polymers market is segmented as antistatic packaging, protection against EMI/ESD, capacitors, batteries, sensors, solar cells, actuators, organic transistors, plastics coated with electrostatic paints, and textiles and fabrics. Electro-active polymers market has been gaining importance with its major application in the areas of ESD/EMI (electrostatic discharge/electromagnetic interference), medical devices, and biomimetics.

The major devices used for the application of electro-active polymers are medical devices, smart fabrics, digital mechtronics, and high strain sensors. The report gives a qualitative analysis about these devices with respect to their characteristics and applications. Market analysis of patents for the last 5 years is also done in the market study.

The global electro-active polymers application market is also segmented with respect to different geographical regions including North America, Europe, Asia, and ROW. The study analyzes the application market for these regions as well and gives market value for different applications. Of the market studied, North America is the largest market for electro-active polymers with an estimated 65% of the global market revenue share in 2011 and is estimated to reach $2.2 billion by 2017.

Scope of the report

The electro-active polymers market research report categorizes the global market on the basis of types, applications and geography in each of the following submarkets:

Types: Inherently conductive polymers, inherently dissipative polymers, conductive plastics, and other electro-active polymers
Applications: Organic light emitting diode, capacitors, batteries, sensors, solar cells, actuators, organic transistors, textiles and fabrics, protection against EMI, protection against ESD, and antistatic packaging.
Geography: North America, Europe, Asia, and ROW
     

Table of Contents :

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.4 ASSUMPTIONS MADE FOR THE REPORT

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 EAP PRODUCTION PROCESS
3.3 MARKET SEGMENTATION
3.4 BUSINESS & MANUFACTURING PROCESSES
3.5 ELECTRO-ACTIVE POLYMER CHARACTERISTICS
3.6 FACTORS INFLUENCING MARKET GROWTH
3.7 WINNING IMPERATIVES
3.7.1 RESEARCH & NEW PRODUCT DEVELOPMENT
3.8 MARKET DYNAMICS
3.8.1 DRIVERS
3.8.1.1 Low cost materials
3.8.1.2 Low driving voltage
3.8.1.3 Light weight & flexible products
3.8.2 RESTRAINT
3.8.2.1 EAP in Nascent Stage
3.8.3 OPPORTUNITIES
3.8.3.1 Biomimetic applications
3.8.3.2 Better surface conductivity
3.9 ELECTRO-ACTIVE POLYMER DEVICES
3.9.1 EAP MEDICAL DEVICES MARKET
3.9.2 EAP SMART FABRICS MARKET
3.9.3 EAP DIGITAL MECHATRONICS MARKET
3.9.4 EAP HIGH STRAIN SENSOR MARKET
3.10 PATENT ANALYSIS

4 ELECTRO-ACTIVE POLYMERS MARKET, BY TYPES
4.1 INTRODUCTION
4.2 INHERENTLY CONDUCTIVE POLYMERS (ICP)
4.2.1 POLYTHIOPHENES
4.2.2 POLYANILINES
4.2.3 POLYPYRROLES
4.2.4 POLYACETYLENES
4.2.5 POLYPHENYLENE VINYLENE (PPV)
4.2.6 POLYFLUORENE
4.2.7 POLYPHENYLENE SULFIDE (PPS)
4.2.8 POLYNAPHTHALENE
4.2.9 DOPING TECHNOLOGIES FOR ICPS
4.2.9.1 Chemical doping technology
4.2.9.2 Electrochemical doping technology
4.2.9.3 Types of dopants
4.2.10 TECHNICAL ASPECTS OF ICPS
4.2.10.1 Molecular weight
4.2.10.2 Improvement in thermal stability
4.2.10.3 Alloys and blends of ICP with resins
4.2.11 BENEFITS OF ICPS
4.2.11.1 Conductivity
4.2.11.2 Electrochromic effect
4.2.11.3 Electroluminescence effect
4.2.11.4 Photoconductivity effect
4.2.11.5 Thermochromic effects
4.3 INHERENTLY DISSIPATIVE POLYMERS
4.4 CONDUCTIVE PLASTICS
4.4.1 ESD/EMI COMPOUNDS
4.4.2 ANTISTATIC ADDITIVES
4.4.3 CARBON/METAL FIBERS
4.4.4 CARBON NANOTUBES
4.4.5 BLENDS OF CONDUCTIVE PLASTICS & POWDER COATINGS
4.5 DIELECTRIC ELASTOMERS
4.5.1 LOW POWER CONSUMPTION
4.5.2 HIGH FORCE-TO-WEIGHT RATIO
4.5.3 SILICONE ELASTOMERS
4.5.4 ACRYLATES
4.5.5 POLYURETHANES
4.6 FERROELECTRETS
4.6.1 POLYPROPYLENE
4.6.2 POLYCARBONATE
4.6.3 CYCLIC OLEFIN COPOLYMER (COC)
4.6.4 FLUORINATED ETHYLENE PROPYLENE

5 ELECTRO-ACTIVE POLYMERS MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 ORGANIC LIGHT EMITTING DIODES
5.3 CAPACITORS
5.3.1 INCREASED RESPONSE RATE
5.3.2 NO RISK OF BURSTING
5.4 BATTERIES
5.4.1 LITHIUM BATTERY
5.4.2 ALL-POLYMER BATTERY
5.4.3 BUTTON BATTERY
5.4.4 AUTOMOTIVE BATTERY
5.4.5 PORTABLE COMPUTER BATTERY
5.5 SENSORS
5.5.1 GAS SENSORS
5.5.2 ODOR SENSORS
5.5.3 CHEMICAL SENSORS
5.5.4 BIOSENSORS
5.6 SOLAR CELLS
5.7 ACTUATORS
5.8 ORGANIC/PLASTIC TRANSISTORS
5.9 TEXTILES & FABRICS
5.10 PROTECTION AGAINST ELECTROMAGNETIC INTERFERENCE (EMI)
5.11 PROTECTION AGAINST ELECTROSTATIC DISCHARGE (ESD)
5.12 ANTISTATIC PACKAGING
5.13 PLASTICS COATED WITH ELECTROSTATIC PAINTS
5.14 OTHER APPLICATIONS

6 GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA
6.5 ROW

7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 MERGERS & ACQUISITIONS
7.3 AGREEMENTS, PARTNERSHIPS, CONTRACTS, JOINT VENTURES & COLLABORATIONS
7.4 NEW PRODUCT DEVELOPMENTS
7.5 OTHERS

8 COMPANY PROFILES
8.1 3M
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 AGFA-GEVAERT N.V.
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCTS & SERVICES
8.2.4 STRATEGY
8.2.5 DEVELOPMENTS
8.3 BAYER AG
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCTS & SERVICES
8.3.4 STRATEGY
8.3.5 DEVELOPMENTS
8.4 CAMBRIDGE DISPLAY TECHNOLOGY LTD (CDT)
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCTS & SERVICES
8.4.4 STRATEGY
8.4.5 DEVELOPMENTS
8.5 CHEVRON PHILLIPS CHEMICAL COMPANY LP
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCTS & SERVICES
8.5.4 STRATEGY
8.5.5 DEVELOPMENTS
8.6 CNANO TECHNOLOGY LTD
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCTS & SERVICES
8.6.4 STRATEGY
8.6.5 DEVELOPMENTS
8.7 CROSSLINK
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCTS & SERVICES
8.7.4 STRATEGY
8.7.5 DEVELOPMENTS
8.8 DANFOSS A/S
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCTS & SERVICES
8.8.4 STRATEGY
8.8.5 DEVELOPMENTS
8.9 EAMEX CORP.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCTS & SERVICES
8.9.4 STRATEGY
8.9.5 DEVELOPMENTS
8.10 EEONYX CORP.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCTS & SERVICES
8.10.4 STRATEGY
8.10.5 DEVELOPMENTS
8.11 ENTHONE INC.
8.11.1 OVERVIEW
8.11.2 FINANCIALS
8.11.3 PRODUCTS & SERVICES
8.11.4 STRATEGY
8.11.5 DEVELOPMENTS
8.12 HYPERION CATALYSIS INTERNATIONAL INC.
8.12.1 OVERVIEW
8.12.2 FINANCIALS
8.12.3 PRODUCTS & SERVICES
8.12.4 STRATEGY
8.12.5 DEVELOPMENTS
8.13 KEMET CORP.
8.13.1 OVERVIEW
8.13.2 FINANCIALS
8.13.3 PRODUCTS & SERVICES
8.13.4 STRATEGY
8.13.5 DEVELOPMENTS
8.14 KONARKA TECHNOLOGIES INC.
8.14.1 OVERVIEW
8.14.2 FINANCIALS
8.14.3 PRODUCTS & SERVICES
8.14.4 STRATEGY
8.14.5 DEVELOPMENTS
8.15 MEDIPACS INC.
8.15.1 OVERVIEW
8.15.2 FINANCIALS
8.15.3 PRODUCTS & SERVICES
8.15.4 STRATEGY
8.15.5 DEVELOPMENTS
8.16 PLEXTRONICS INC.
8.16.1 OVERVIEW
8.16.2 FINANCIALS
8.16.3 PRODUCTS & SERVICES
8.16.4 STRATEGY
8.16.5 DEVELOPMENTS
8.17 POLYONE CORP.
8.17.1 OVERVIEW
8.17.2 FINANCIALS
8.17.3 PRODUCTS & SERVICES
8.17.4 STRATEGY
8.17.5 DEVELOPMENTS
8.18 PREMIX OY
8.18.1 OVERVIEW
8.18.2 FINANCIALS
8.18.3 PRODUCTS & SERVICES
8.18.4 STRATEGY
8.18.5 DEVELOPMENTS
8.19 RIEKE METALS INC.
8.19.1 OVERVIEW
8.19.2 FINANCIALS
8.19.3 PRODUCTS & SERVICES
8.19.4 STRATEGY
8.19.5 DEVELOPMENTS
8.20 RTP COMPANY
8.20.1 OVERVIEW
8.20.2 FINANCIALS
8.20.3 PRODUCTS & SERVICES
8.20.4 STRATEGY
8.20.5 DEVELOPMENTS
8.21 SAUDI BASIC INDUSTRIES CORP.
8.21.1 OVERVIEW
8.21.2 FINANCIALS
8.21.3 PRODUCTS & SERVICES
8.21.4 STRATEGY
8.21.5 DEVELOPMENTS
8.22 SIGMA-ALDRICH CORP.
8.22.1 OVERVIEW
8.22.2 FINANCIALS
8.22.3 PRODUCTS & SERVICES
8.22.4 STRATEGY
8.22.5 DEVELOPMENTS
8.23 TDA RESEARCH INC.
8.23.1 OVERVIEW
8.23.2 FINANCIALS
8.23.3 PRODUCTS & SERVICES
8.23.4 STRATEGY
8.23.5 DEVELOPMENTS
8.24 THE LUBRIZOL CORP.
8.24.1 OVERVIEW
8.24.2 FINANCIALS
8.24.3 PRODUCTS & SERVICES
8.24.4 STRATEGY
8.24.5 DEVELOPMENTS
8.25 TICONA GMBH
8.25.1 OVERVIEW
8.25.2 FINANCIALS
8.25.3 PRODUCTS & SERVICES
8.25.4 STRATEGY
8.25.5 DEVELOPMENTS

APPENDIX
? U.S. PATENTS
? EUROPE PATENTS
? ASIA PATENTS

LIST OF TABLES

TABLE 1 GLOBAL ELECTRO-ACTIVE POLYMERS MARKET REVENUE,
BY SEGMENTS, 2010 – 2017 ($MILLION)
TABLE 2 GLOBAL ELECTRO-ACTIVE POLYMERS MARKET VOLUME, BY SEGMENTS, 2010 – 2017 (MILLION POUNDS)
TABLE 3 EAP MARKET REVENUE, BY DEVICES, 2012 – 2017 ($MILLION)
TABLE 4 EAP MEDICAL DEVICES MARKET REVENUE, BY GEOGRAPHY,
2012 – 2017 ($MILLION)
TABLE 5 EAP SMART FABRICS MARKET REVENUE, BY GEOGRAPHY,
2012 – 2017 ($MILLION)
TABLE 6 EAP DIGITAL MECHATRONICS MARKET REVENUE, BY GEOGRAPHY,
2012 – 2017 ($MILLION)
TABLE 7 EAP HIGH STRAIN SENSOR MARKET REVENUE, BY GEOGRAPHY,
2009 – 2014 ($MILLION)
TABLE 8 GLOBAL INHERENTLY CONDUCTIVE POLYMERS MARKET REVENUE,
BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 9 INHERENTLY CONDUCTIVE POLYMERS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 MAJOR ICP SUPPLIERS
TABLE 11 POLYTHIOPHENES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 12 POLYANILINES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 13 POLYACETYLENES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 14 POLYPHENYLENE VINYLENE MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 15 POLYFLUORENE MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 16 POLYPHENYLENE SULFIDE MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 17 POLYNAPHTHALENE MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 18 CHEMICALS USED FOR DOPING ICP
TABLE 19 INHERENTLY DISSIPATIVE POLYMERS MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 20 GLOBAL CONDUCTIVE PLASTICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 21 CONDUCTIVE PLASTICS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 22 ESD/EMI COMPOUNDS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 23 ANTISTATIC ADDITIVES IN EAP MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 24 CARBON/METAL FIBERS IN EAP MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 25 CARBON NANOTUBES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 26 SURFACE RESISTIVITY OF DIFFERENT MATERIALS
TABLE 27 PROPERTIES OF ICP VS CONDUCTIVE PLASTICS
TABLE 28 COMPARISON OF DIELECTRIC ELASTOMER ACTUATORS VS. VOICE COILS
TABLE 29 COMPARISON OF STRETCHABILITY VS CHANGE IN RESISTANCE OF SILICONE
TABLE 30 POLYURETHANE STRETCHABILITY VS RESISTIVITY
TABLE 31 GLOBAL ELECTRO-ACTIVE POLYMERS MARKET REVENUE,
BY APPLICATIONS, 2010 – 2017 ($MILLION)
TABLE 32 ADVANTAGES & DISADVANTAGES OF OLED OVER CONVENTIONAL LED
TABLE 33 EAP OLED MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 34 ELECTRO-ACTIVE POLYMER CAPACITORS VS ELECTROLYTIC CAPACITORS
TABLE 35 CAPACITORS IN EAP MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 36 GLOBAL BATTERIES MARKET REVENUE, BY SEGMENTS,
2010 – 2017 ($MILLION)
TABLE 37 SECONDARY BATTERIES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 38 PRIMARY BATTERIES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 39 BATTERIES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 40 GLOBAL EAP BATTERIES MARKET REVENUE, BY PRODUCTS,
2010 – 2017 ($THOUSAND)
TABLE 41 EAP LITHIUM BATTERIES MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 42 EAP BUTTON BATTERY MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 43 EAP AUTOMOTIVE BATTERY MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 44 EAP PORTABLE COMPUTER BATTERY MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($THOUSAND)
TABLE 45 SENSORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 46 EAP SENSORS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 47 EAP SOLAR CELLS MARKET REVENUE, BY GEOGRAPHY,
2012 – 2017 ($THOUSAND)
TABLE 48 EAP ACTUATORS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 49 EAP ORGANIC/PLASTIC TRANSISTOR MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($THOUSAND)
TABLE 50 EAP TEXTILES & FABRICS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($THOUSAND)
TABLE 51 EAP ELECTROMAGNETIC INTERFERENCE MARKET REVENUE,
BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 52 EAP ELECTROSTATIC DISCHARGE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 53 ELECTRO-ACTIVE POLYMERS MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
TABLE 54 NORTH AMERICA: ELECTRO-ACTIVE POLYMERS MARKET REVENUE,
BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 55 EUROPE: ELECTRO-ACTIVE POLYMERS MARKET REVENUE,
BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 ASIA: ELECTRO-ACTIVE POLYMERS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 57 ROW: ELECTRO-ACTIVE POLYMERS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 58 MERGERS & ACQUISITIONS, 2010 – 2012
TABLE 59 AGREEMENTS, PARTNERSHIPS, CONTRACTS, JOINT VENTURES & COLLABORATIONS, 2010-2012
TABLE 60 NEW PRODUCT DEVELOPMENTS, 2010 – 2012
TABLE 61 OTHERS, 2010 – 2012
TABLE 62 3M CORP: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 63 3M CORP: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 64 AGFA-GEVAERT: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 65 AGFA-GEVAERT: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 66 AGFA-GEVAERT: PRODUCTS & ITS APPLICATION
TABLE 67 BAYER MATERIALSCIENCE: MARKET REVENUE, BY SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 68 BAYER MATERIALSCIENCE: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 69 DANFOSS: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 70 DANFOSS: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 71 KEMET CORP: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 72 KEMET CORP: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 73 POLYONE CORP: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 74 POLYONE CORP: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 75 SABIC: MARKET REVENUE, BY BUSINESS SEGMENTS,
2009 – 2010 ($MILLION)
TABLE 76 SIGMA-ALDRICH: MARKET REVENUE, BY BUSINESS SEGMENTS,
2010 – 2011 ($MILLION)
TABLE 77 SIGMA-ALDRICH: MARKET REVENUE, BY GEOGRAPHY,
2010 – 2011 ($MILLION)
TABLE 78 LUBRIZOL CORP: MARKET REVENUE, BY BUSINESS SEGMENTS,
2009 – 2010 ($MILLION)
TABLE 79 LUBRIZOL CORP: MARKET REVENUE, BY GEOGRAPHY,
2009 – 2010 ($MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL ELECTRO-ACTIVE POLYMERS MARKET
FIGURE 2 EAP PRODUCTION PROCESS
FIGURE 3 GLOBAL ELECTRO-ACTIVE POLYMERS MARKET REVENUE, BY PRODUCT TYPES, 2011
FIGURE 4 BUSINESS & MANUFACTURING PROCESS IN THE EAP INDUSTRY
FIGURE 5 FACTORS INFLUENCING EAP MARKET GROWTH
FIGURE 6 IMPACT OF DRIVERS ON GLOBAL ELECTRO-ACTIVE POLYMERS MARKET
FIGURE 7 IMPACT OF RESTRAINT ON GLOBAL ELECTRO-ACTIVE POLYMERS MARKET
FIGURE 8 ELECTRO-ACTIVE POLYMER DEVICES
FIGURE 9 PATENTS ANALYSIS, BY MARKET PLAYERS, 2008 – 2012
FIGURE 10 INHERENTLY CONDUCTIVE POLYMERS, BY TYPES
FIGURE 11 TYPES OF CONDUCTIVE PLASTICS
FIGURE 12 OPPORTUNITY MATRIX
FIGURE 13 ELECTRO-ACTIVE POLYMERS, BY END-USERS
FIGURE 14 ELECTRO-ACTIVE POLYMER BATTERIES, BY TYPES
FIGURE 15 ELECTRO-ACTIVE POLYMER SENSORS, BY TYPES
FIGURE 16 TRENDS IN THE GLOBAL EAP MARKET REVENUE, BY GEOGRAPHY,
2010 – 2017 ($MILLION)
FIGURE 17 KEY GROWTH STRATEGIES, 2010 – 2012

2012 Latest Report: Global Blood Plasma Market Report: 2011 Edition

Global Blood Plasma Market Report: 2011 Edition

For more details on the content of each report and ordering information please visit:

http://www.aarkstore.com/reports/Global-Blood-Plasma-Market-Report-2011-Edition-40312.html

Recent scientific studies are leading to the discovery of new proteins in the blood plasma and their uses to treat hitherto unresolved medical conditions. The market for blood plasma products has shown continuous growth in the past years growing at a CAGR of around 10% during 2001-10 and is projected to expand steadily in the years to come.

The North American region is a major revenue generator in the global blood plasma industry, accounting for approximately 40% share of the worldwide market, followed by European Union, and other regions. The use of blood plasma products in developed countries is well established; however, their demand in emerging countries, such as China and India is persistently on the rise.

With scientific, technological advances in medical research in developed and developing countries, there is now much room for increased usage of IVIG. New indications are being explored whereby various blood plasma products are being put to new uses for treatment of old and new diseases. Further, the entry of new recombinant products, which compete with existing blood plasma products, have started a price competition creating a downward pressure on prices. The deficiency of A1PI is still an undiagnosed and untreated disease in North America which provides significant scope and potential for the increased use of blood plasma products in the treatment of the affected people.

Besides this, bleeding disorders and related diseases are growing requiring increased usage of blood plasma products. Ageing population is on the constant rise worldwide and the aged people are prone to develop diseases requiring more demand of blood derivatives. Furthermore, the economic growth is also responsible for higher utilization of blood plasma derivatives. Also, new proteins are being discovered in blood plasma, which are being put to new uses for treatment of various diseases.

Despite, several factors suggesting future growth of the market, the high prices of blood plasma products continues to be a significant challenge. Furthermore, even in the wake of improving economies and rising GDP's, income disparities keep the use of plasma derived products beyond the reach of numerous patients.

The leading players of the blood plasma market include: Baxter, Grifols, CSL, and Octapharma, among others, competing mainly on the basis of product pricing and performance, supply of the products, and continuous offering of new and innovative plasma derivatives. Moreover, the existence of several players operating at a domestic level, entry of new players, and agreements with government agencies, academic and research institutions make the plasma market landscape intensely competitive.

The report provides an analysis of the global blood plasma market. It also discusses the major trends, growth drivers and potential markets for blood plasma market. The report presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Contents :

1. Overview

1.1 Introduction
1.2 Plasma Collection Process
1.3 Types of Blood Plasma Proteins
1.4 Value Chain of Plasma market

2. Blood Plasma Market Overview

2.1 Global Blood Plasma Market
2.2 Market by Segments

2.2.1 IVIG Market

Market Value
Uses of IVIG
Market Share
Other Statistics

2.2.2 Clotting Factors Market

Hemophilia B Treatment Revenues
Factor IX Market

2.2.3 Albumin Market
2.2.4 A1PI Market

2.3 Market by Region

2.2.1 The US Blood Plasma Market

Plasma Derivatives Market Value
IVIG Distribution Growth
Market Share

2.2.2 Canada Blood Plasma Market

Blood Derivatives Market Value
Immunoglobulin Market Share

2.2.3 China Blood Plasma Market

Market Overview
Market Segments
Albumin Market Value
Albumin Market Share
IVIG and Factor VIII Market
Factor VIII Market Forecast
Factor VIII Market Share

2.4 Industry Cost Structure

3. Market Dynamics

3.1 Key Trends

3.1.1 Potential for Increased Usage of IVIG
3.1.2 Discovery of New Conditions to Expand Market Potential
3.1.3 Treatments for A1PI Deficiency Limited to Prevention Only
3.1.4 New Recombinant Products to Start Price War

3.2 Growth Drivers

3.2.1 Growing Number of Bleeding Disorders
3.2.2 Growing Aging Population
3.2.3 Rising Global GDP per Capita
3.2.4 Discovery of New Proteins in Blood Plasma

3.3 Challenges

3.3.1 High Prices of Plasma Derived Drugs
3.3.2 Developing Countries–Delay in Switch to Recombinant Factors

4. Competitive Scenario

Competitive Overview
Market Share

5. Company Profiles

5.1 Baxter International

Business Description
Key Financials
Business Strategies
Investment in Research & Development
Growth through Sustainable Development

5.2 CSL Limited

Business Description
Key Financials
Business Strategies
Investment in New Facilities
Continuous Offering of New Products

5.3 Grifols

Business Description
Key Financials
Business Strategies
Geographical Diversification
Growth through Acquisitions

5.4 Octapharma

Business Description
Key Financials
Business Strategies
Constant Product Innovation
Investment in Research Facilities

6. Market Outlook

6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

Plasma Derivatives Products per Liter of Plasma
The Plasma Chain
Value Chain of the Plasma-Derived Products Market
Global Blood Plasma Market, 2000-2010
Global Blood Plasma Market by Products, 2010
Global IVIG Market Revenues, 2004-2010
Uses of IVIG, 2010
IVIG Use per Inhabitant by Country, 2010
Global IVIG Market Share by Companies, 2010
Hemophilia B Treatment Revenues, 2011E
Factor VIII use per Inhabitant, 2010
A1PI Deficiency Counts in Europe and North America, 2010
The Global Plasma Market by Region, 2010
Blood Collection in the US
The US Plasma Derivatives Market, 2010
The US IVIG Distribution Growth, Sep08-May11
Number of Plasma Centers in the US, 2000-2010
Cost Structure of Operating Plasma Collection Center in the US
The US’ Blood Plasma Market by Companies, 2010
Canadian Blood Derivatives Market by Product Category, 2006-07 to 2009-10
Canada’s Immunoglobulin Market Share by Company, 2003-04 to 2010-11
Five-year Immunoglobulin trend by 1000 grams, 2006-07 to 2010-11
Chinese Blood Plasma Market by Product Category, 2010
China’s Albumin Market Sales, 2010
Albumin Prices in China, 2010
China’s Albumin Market Share by Companies, 2010
Albumin Usage Rate in China, 2010
Leading Suppliers of Albumin into China, 2010
China’s IVIG and Factor VIII Market, 2010
IVIG and Factor VIII Prices in China, 2010
China’s Factor VIII Market Share by Companies, Jan10-Oct10
Manufacturing Cost Split for Plasma Fractionation, September 2011
Global IVIG Consumption per Capita, 2010
Potential for Increased Use of IVIG in the US, 2010
A1PI - Largely Undiagnosed Disease in North America and EU
Global Ageing Population, 2005-2012F
Percentage of Recombinant Factor VIII in total Factor VIII Market, 2010
Grifols Market Share by Company, 2010
No. of Plasma Collection Centers of Leading in the US, 2010
Baxter’s Revenue Breakdown by Business Segments, 2010
Baxter’s Revenues and Net Income, 2006-2010
CSL’s Sales by Major Products, FY2011
Grifol’s Revenue Breakdown by Business Segments, 2010
Grifol’s Revenues and Net Income, 2006-2010
Octapahrma’s Revenues and Net Income, 2006-2010
Global Blood Plasma Market Forecasts, 2009-2014F

List of Tables

Output per Liter of Plasma
Plasma Donation vs. Whole Blood Donation
Recovered plasma vs. Source plasma
Forecast of Plasma for Fractionation by Region if IVIG is approved for Alzheimer’s disease Treatment, 2007-2018
Forecast of Plasma for Fractionation by Region if IVIG is not approved for Alzheimer’s disease Treatment, 2007-2018
Market Characteristics for Hemophilia B Treatments, 2010
Global Factor IX Market Estimates: Revenue Growth & Composition, 2011E-2020E
China Factor VIII Market Forecast, FY10-FY20E
IVIG being explored in New Indications, 2010
A1PI Products
Non-Long Acting Recombinant Factor VIII and IX under Late-Stage Development
Long Acting Recombinant Factor VIII and IX under Late-Stage Development
Global Prices of Blood Derivatives, 2010
CSL Limited’s Net Revenues and Net income, FY2010 & FY2011
Dependent & Independent Variables, 2005-2010
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

2012 Latest Report: Global Smokeless Tobacco Market Report: 2012 Edition

2012 Latest Report: Global Smokeless Tobacco Market Report: 2012 Edition

For more details on the content of each report and ordering information please contact:

http://www.aarkstore.com/reports/Global-Smokeless-Tobacco-Market-Report-2012-Edition-92188.html

Historical evidence and archeological finds suggest that the practice of smoking tobacco by the mankind has been an unbroken tradition since thousands of years. With high pitched industrialization, extreme environmental damage by factors like wars and chemicals, and other human practices, the serious ill effects on health are being experienced by the use of smoking tobacco. Scientific developments have helped in the identification of these health risks, while technological advancements have compelled the society to be rightly aware of the health hazards involved. In the search for solutions, alternatives in the form of smokeless products, which are less harmful, have been developed and are being willingly adopted by the people worldwide.

The major markets for smokeless tobacco products are the US and the Scandinavian region, with the former being the world's largest market in the moist snuff product category, while latter is the leading provider of various snus tobacco varieties. Within Scandinavia, Sweden is the largest market for snus followed by Norway. Though, snus is a traditionally a Swedish product yet its market is fast expanding in regions outside Scandinavia like in the US, Canada, and Vietnam among others.

Reducing consumption of cigarettes due to awareness about health risks is creating space for greater use of smokeless products. Further, the rising incomes of people coupled with growing percentage of people, in the rising population, resorting to the use of smokeless product options is driving the market towards growth. Development of new products like snus made from ecologically grown tobacco and snuff with ultra low carcinogens, with the help of scientific research, is also providing people with new and less harmful alternatives thus strengthening the market for such products. Though less harmful compared to smoking tobacco, health risks do persists with the use of smokeless tobacco products. A debate continues about the threat of these products to public health at large and threat to children who accidently ingest such products.

The competition in the market for smokeless tobacco products is intense with the leading players being Swedish Match, Altria Group, and Reynolds American. Swedish Match is the leading player in the Scandinavian snus market, while Altria Group, Inc. holds the maximum market share in the US's moist snuff market. The factors such as quality, pricing, brand imaging, customer loyalty, and new product introductions, among others determine the competitive positioning of the companies operating in the global smokeless tobacco market.

The report analyzes the global smokeless tobacco industry including its market size and geographical segmentation. The report also analyses the key trends, drivers and challenges of the market. Further, the report highlights the strategies of top smokeless tobacco manufacturers – Swedish Match, Altria and Reynolds American Inc.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
 
     

Table of Contents :

1. Smokeless Tobacco: An Overview

1.1 Introduction
1.2 Types of Smokeless Tobacco

1.2.1 Chewing Tobacco
1.2.2 Snuff
1.2.3 Snus

2. Smokeless Tobacco - Market Structure

2.1 Global Snus and Moist Snuff Market
2.2 The US Smokeless Tobacco Market

2.2.1 The US Moist Snuff Market

Market Value
Market Volume
Key Segments

2.2.2 The US Snus Market

Overview
Market Volume

2.3 Scandinavian Snus Market

Overview
Market Volume
Price Trend

2.3.1 The Swedish Snus Market

Market Volume
Snus Consumers

2.3.2 The Norwegian Snus Market

Overview
Market Volume

2.4 Snus Markets outside Scandinavia and the US

2.4.1 Taiwan
2.4.2 Canada
2.4.3 Indonesia
2.4.4 India

3. Market Dynamics

3.1 Growth Drivers

3.1.1 Declining Industry Cigarette Volumes
3.1.2 Rising Personal Income
3.1.3 Growth in Population

3.2 Industry Developments

3.2.1 Snus Made From Ecologically Grown Tobacco
3.2.2 Moist Snuff Tobacco Product with Ultra-Low Carcinogen

3.3 Challenges

3.3.1 Health Risks Associated with Smokeless Tobacco
3.3.2 Regulatory Issues

4. Competitive Scenario

4.1 Competition in the Scandinavian Market
4.2 Competition in the US Market

5. Company Profiles

5.1 Altria Group Inc.

Business Description
Key Financials
Business Strategies
Establishing Leadership Position
Introduction of New Product Technologies

5.2 Swedish Match

Business Description
Key Financials
Business Strategies
Focus on Quality and Innovation
Growth Opportunities outside Scandinavia & US

5.3 Reynolds American Inc.

Business Description
Key Financials
Business Strategies
Strong Portfolio of Profitable Brands
Transformation due to Shifting Consumer Preferences

6. Market Outlook

6.1 Market Forecast
6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

Production Process of Snuff
Top 3 Moist Snuff Brands Shipments to Retail, 2009-2011
US Moist Snuff Market Volumes, 2000-2010
US Moist Smokeless Tobacco Products Sales, 2009-2010
US Moist Snuff Market Volumes by Segments, 2000-2010
US Market for Swedish Snus, 2008-2010
Scandinavian Snus Consumption Volumes, 2000-2011E
Snus Volume Sale in Scandinavia by Type, 2010
Price Increases in Scandinavia, 2012E
Number of Snus Consumers in Sweden, 2010
Sales of Snus in Sweden, 2000-2010
Growth in Norwegian Snus Market (in volume terms), 2009-2010
Number of Tobacco Users in India by Type, 2010
Value of Tobacco Market in India by Types, 2010
Average Spend per User on Different Types of Tobacco in India, 2010
Geographical Segmentation of Consumption of Smokeless Tobacco in India, 2010
US Cigarettes Consumption, 2001-2010
Leading Players in the Swedish Snus Market (by Volume), Oct-Nov 2010
Leading Players in the Norwegian Snus Market (by Volume), Oct-Nov 2010
Competition in the US Snuff Market (by volume), October 2011
Altria’s Revenue Share by Business Segments, 2011
Altria’s Revenues and Net Income, 2007-2011
Swedish Match’s Revenue Share by Business Segments, 2011
Swedish Match’s Revenues and Net Income, 2008-2011
Reynolds America Inc.’s Revenue Share by Business Segments, 2011
Reynolds American Inc.’s Revenues and Net Income, 2007-2011
US Moist Smokeless Tobacco Products Sales Forecast, 2010–2014F

List of Tables

Taiwan’s Snus Market, 2009-2014E
Canada’s Snus Market, 2009-2014E
Indonesia’s Snus Market, 2009-2014E
Swedish Snus - Value and Volume Market Shares, April-May 2011
Swedish Match Market Share (by brands) in US Moist Snuff, Oct 2010-Jan 2011
Smokeless Products Shipment Volume, 2010 & 2009
Dependent & Independent Variables, 2004-2010
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output